MILESTONE (MMD): Abstract Acceptance for Presentation at the Euroanaesthesia 2016 Congress - raport 5

The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today announced that its abstract entitled “A randomized, controlled, parallel group, multicenter, pivotal study to assess the safety and effectiveness of the epidural space verification with the CompuFlo® Epidural Computer Controlled System (CompuFlo)” has been accepted for presentation at the prestigious Euroanaesthesia 2016 Congress taking place May 28-30, 2016 in London.

The abstract was authored by Dr. Douglas Dobecki, Diplomate of the American Board of Anesthesiology and a double-board certified anesthesiologist and interventional pain management expert from the San Diego Pain Institute. The abstract will be published in the supplement of the European Journal of Anaesthesiology that will coincide with the meeting.

Milestone Medical designed the study in conjunction with its Scientific Advisory Board, and in agreement with the U.S. Food and Drug Administration (FDA), to assess the safety and effectiveness of the pressure sensing technology in identification of the epidural space.

The Board of Directors of the Issuer is pleased to announce the acceptance of an abstract regarding our epidural instrument in yet another leading anesthesia journal, this time in Europe, and looks forward to presenting the findings at the Euroanaesthesia 2016 Congress in London.

Legal basis: § 3 subparagraph 1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market".

Osoby reprezentujące spółkę:
Joseph D'Agostino - Chief Financial Officer